automated cell therapy

Breakthrough Technology Solving Cell Therapy Bottleneck

🧬 The emergence of CRISPR-based gene editing has revolutionized cell therapy research. 🔬 However, there is a significant bottleneck in the development and manufacturing of these therapies. ⚙️ Critical to CRISPR-based gene editing is the effective delivery of editing components to target cells. 🔬 Scaling the process for industrial manufacturing is a challenge, especially for therapies that require ex vivo editing of patient cells. ⚡ Electroporation technology, specifically flow electroporation, offers a solution to this bottleneck. 📈 Flow electroporation can transfect billions of cells at a time, providing scalability and process standardization. 💉 This technology is already being used to enable CRISPR-based therapies and has played a critical role in the commercial approval of the first CRISPR-based cell therapy. 🧬 As companies and scientists develop more advanced cellular therapies, flow electroporation will continue to expand access to non-viral approaches. 🌍 While questions remain about the long-term safety and efficacy of genome editing therapies, CRISPR-related technologies offer new avenues for treating diseases.